Study Protocol: Using Deep-Brain Stimulation, Multimodal Neuroimaging and Neuroethics to Understand and Treat Severe Enduring Anorexia Nervosa

Rebecca J Park, Jessica C Scaife, Tipu Z Aziz, Rebecca J Park, Jessica C Scaife, Tipu Z Aziz

Abstract

Background: Research suggests that altered eating and the pursuit of thinness in anorexia nervosa (AN) are, in part, a consequence of aberrant reward circuitry. The neural circuits involved in reward processing and compulsivity overlap significantly, and this has been suggested as a transdiagnostic factor underpinning obsessive compulsive disorder, addictions and eating disorders. The nucleus accumbens (NAcc) is central to both reward processing and compulsivity. In previous studies, deep-brain stimulation (DBS) to the NAcc has been shown to result in neural and symptomatic improvement in both obsessive compulsive disorder and addictions. Moreover, in rats, DBS to the NAcc medial shell increases food intake. We hypothesise that this treatment may be of benefit in severe and enduring anorexia nervosa (SE-AN), but first, feasibility and ethical standards need to be established. The aims of this study are as follows: (1) to provide feasibility and preliminary efficacy data on DBS to the NAcc as a treatment for SE-AN; (2) to assess any subsequent neural changes and (3) to develop a neuroethical gold standard to guide applications of this treatment.

Method: This is a longitudinal study of six individuals with SE-AN of >7 years. It includes an integrated neuroethical sub-study. DBS will be applied to the NAcc and we will track the mechanisms underpinning AN using magnetoelectroencephalography, neuropsychological and behavioural measures. Serial measures will be taken on each intensively studied patient, pre- and post-DBS system insertion. This will allow elucidation of the processes involved in symptomatic change over a 15-month period, which includes a double-blind crossover phase of stimulator on/off.

Discussion: Novel, empirical treatments for SE-AN are urgently required due to high morbidity and mortality costs. If feasible and effective, DBS to the NAcc could be game-changing in the management of this condition. A neuroethical gold standard is crucial to optimally underpin such treatment development.

Clinical trial registration: The study is ongoing and registered with www.ClinicalTrials.gov, https://ichgcp.net/clinical-trials-registry/NCT01924598, 22 July, 2013. It has full ethical and HRA approval (Project ID 128658).

Keywords: anorexia nervosa; clinical trial; compulsivity; deep-brain stimulation; reward; treatment.

Figures

Figure 1
Figure 1
Schedule of study procedures.

References

    1. Keel PK, Dorer DJ, Eddy KT, Franko D, Charatan DL, Herzog DB. Predictors of mortality in eating disorders. Arch Gen Psychiatry (2003) 60(2):179–83.10.1001/archpsyc.60.2.179
    1. Franko DL, Keshaviah A, Eddy KT, Krishna M, Davis MC, Keel PK, et al. A longitudinal investigation of mortality in anorexia nervosa and bulimia nervosa. Am J Psychiatry (2013) 170(8):917–25.10.1176/appi.ajp.2013.12070868
    1. Steinhausen HC. The outcome of anorexia nervosa in the 20th century. Am J Psychiatry (2002) 159(8):1284–93.10.1176/appi.ajp.159.8.1284
    1. Bulik CM, Sullivan PF, Tozzi F, Furberg H, Lichtenstein P, Pedersen NL. Prevalence, heritability, and prospective risk factors for anorexia nervosa. Arch Gen Psychiatry (2006) 63(3):305–12.10.1001/archpsyc.63.3.305
    1. Watson H, Bulik C. Update on the treatment of anorexia nervosa: review of clinical trials, practice guidelines and emerging interventions. Psychol Med (2012) 10:1–24.10.1017/S0033291712002620
    1. Crow SJ, Mitchell JE, Roerig JD, Steffen K. What potential role is there for medication treatment in anorexia nervosa? Int J Eat Disord (2009) 42(1):1–8.10.1002/eat.20576
    1. Balestrieri M, Oriani MG, Simoncini A, Bellantuono C. Psychotropic drug treatment in anorexia nervosa. Search for differences in efficacy/tolerability between adolescent and mixed-age population. Eur Eat Disord Rev (2013) 21(5):361–73.10.1002/erv.2240
    1. Frank GK, Shott ME. The role of psychotropic medications in the management of anorexia nervosa: rationale, evidence and future prospects. CNS Drugs (2016) 30(5):419–42.10.1007/s40263-016-0335-6
    1. Park RJ, Godier LR, Cowdrey FA. Hungry for reward: how can neuroscience inform the development of treatment for anorexia nervosa? Behav Res Ther (2014) 62:47–59.10.1016/j.brat.2014.07.007
    1. Cowdrey FA, Filippini N, Park RJ, Smith SM, McCabe C. Increased resting state functional connectivity in the default mode network in recovered anorexia nervosa. Hum Brain Mapp (2012) 35(2):483–91.10.1002/Hbm.22202
    1. Gaudio S, Wiemerslage L, Brooks SJ, Schioth HB. A systematic review of resting-state functional-MRI studies in anorexia nervosa: evidence for functional connectivity impairment in cognitive control and visuospatial and body-signal integration. Neurosci Biobehav Rev (2016) 71:578–89.10.1016/j.neubiorev.2016.09.032
    1. Scaife J, Godier L, Filippini N, Harmer C, Park R. Reduced resting state functional connectivity in current and recovered restrictive anorexia nervosa. Front Psychiatry (2017) 8:30.10.3389/fpsyt.2017.00030
    1. Godier LR, Scaife JC, Braeutigam S, Park RJ. Enhanced early neuronal processing of food pictures in anorexia nervosa: a magnetoencephalography study. Psychiatry J (2016) 2016:1795901.10.1155/2016/1795901
    1. Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry (2008) 64(6):461–7.10.1016/j.biopsych.2008.05.034
    1. Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B, et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry (2010) 67(2):110–6.10.1016/j.biopsych.2009.09.013
    1. Lozano AM, Giacobbe P, Hamani C, Rizvi SJ, Kennedy SH, Kolivakis TT, et al. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg (2012) 116(2):315–22.10.3171/2011.10.JNS102122
    1. Bergfeld IO, Mantione M, Hoogendoorn ML, Ruhe HG, Horst F, Notten P, et al. Impact of deep brain stimulation of the ventral anterior limb of the internal capsule on cognition in depression. Psychol Med (2017) 47:1647–58.10.1017/S0033291717000113
    1. Lipsman N, Neimat JS, Lozano AM. Deep brain stimulation for treatment-refractory obsessive–compulsive disorder: the search for a valid target. Neurosurgery (2007) 61(1):1–11; discussion 11–3.10.1227/01.neu.0000279719.75403.f7
    1. de Haan S, Rietveld E, Stokhof M, Denys D. Becoming more oneself? Changes in personality following DBS treatment for psychiatric disorders: experiences of OCD patients and general considerations. PLoS One (2017) 12(4):e0175748.10.1371/journal.pone.0175748
    1. Velasques B, Diniz C, Teixeira S, Cartier C, Peressutti C, Silva F, et al. Deep brain stimulation: a new treatment in mood and anxiety disorders. CNS Neurol Disord Drug Targets (2014) 13(6):961–71.10.2174/1871527313666140612122929
    1. Greenberg BD, Gabriels LA, Malone DA, Jr, Rezai AR, Friehs GM, Okun MS, et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive–compulsive disorder: worldwide experience. Mol Psychiatry (2010) 15(1):64–79.10.1038/mp.2008.55
    1. Halmi KA, Eckert E, Marchi P, Sampugnaro V, Apple R, Cohen J. Comorbidity of psychiatric diagnoses in anorexia nervosa. Arch Gen Psychiatry (1991) 48(8):712–8.10.1001/archpsyc.1991.01810320036006
    1. Godier LR, Park RJ. Compulsivity in anorexia nervosa: a transdiagnostic concept. Front Psychol (2014) 5:778.10.3389/fpsyg.2014.00778
    1. Godier LR, Park RJ. Does compulsive behavior in anorexia nervosa resemble an addiction? A qualitative investigation. Front Psychol (2015) 6:1608.10.3389/fpsyg.2015.01608
    1. McLaughlin NC, Didie ER, Machado AG, Haber SN, Eskandar EN, Greenberg BD. Improvements in anorexia symptoms after deep brain stimulation for intractable obsessive–compulsive disorder. Biol Psychiatry (2013) 73(9):e29–31.10.1016/j.biopsych.2012.09.015
    1. Israel M, Steiger H, Kolivakis T, McGregor L, Sadikot AF. Deep brain stimulation in the subgenual cingulate cortex for an intractable eating disorder. Biol Psychiatry (2010) 67(9):e53–4.10.1016/j.biopsych.2009.11.016
    1. Wu H, Van Dyck-Lippens PJ, Santegoeds R, van Kuyck K, Gabriels L, Lin G, et al. Deep-brain stimulation for anorexia nervosa. World Neurosurg (2013) 80(3–4):e21–10.10.1016/j.wneu.2012.06.039
    1. Blomstedt P, Naesström M, Bodlund O. Deep brain stimulation in the bed nucleus of the stria terminalis and medial forebrain bundle in a patient with major depressive disorder and anorexia nervosa. Clin Case Rep (2017) 5:679–84.10.1002/ccr3.856
    1. Lipsman N, Woodside DB, Giacobbe P, Hamani C, Carter JC, Norwood SJ, et al. Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial. Lancet (2013) 381(9875):1361–70.10.1016/S0140-6736(12)62188-6
    1. Lipsman N, Lam E, Volpini M, Sutandar K, Twose R, Giacobbe P, et al. Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial. Lancet Psychiatry (2017) 4(4):285–94.10.1016/S2215-0366(17)30076-7
    1. Park RJ, Dunn BD, Barnard PJ. Schematic models and modes of mind in anorexia nervosa I: a novel process account. Int J Cogn Ther (2011) 4(4):415–37.10.1521/ijct.2011.4.4.415
    1. Park RJ, Dunn BD, Barnard PJ. Schematic models and modes of mind in anorexia nervosa II: implications for treatment and course. Int J Cogn Ther (2012) 5(1):86–98.10.1521/ijct.2012.5.1.86
    1. Fladung AK, Gron G, Grammer K, Herrnberger B, Schilly E, Grasteit S, et al. A neural signature of anorexia nervosa in the ventral striatal reward system. Am J Psychiatry (2010) 167(2):206–12.10.1176/appi.ajp.2009.09010071
    1. Fladung AK, Schulze UM, Scholl F, Bauer K, Gron G. Role of the ventral striatum in developing anorexia nervosa. Transl Psychiatry (2013) 3:e315.10.1038/tp.2013.88
    1. Cowdrey FA, Finlayson G, Park RJ. Liking compared with wanting for high- and low-calorie foods in anorexia nervosa: aberrant food reward even after weight restoration. Am J Clin Nutr (2013) 97(3):463–70.10.3945/ajcn.112.046011
    1. Scaife JC, Godier LR, Reinecke A, Harmer CJ, Park RJ. Differential activation of the frontal pole to high vs low calorie foods: the neural basis of food preference in anorexia nervosa? Psychiatry Res (2016) 258:44–53.10.1016/j.pscychresns.2016.10.004
    1. Wagner A, Aizenstein H, Venkatraman VK, Bischoff-Grethe A, Fudge J, May JC, et al. Altered striatal response to reward in bulimia nervosa after recovery. Int J Eat Disord (2010) 43(4):289–94.10.1002/eat.20699
    1. Berridge KC, Kringelbach ML. Pleasure systems in the brain. Neuron (2015) 86(3):646–64.10.1016/j.neuron.2015.02.018
    1. van der Plasse G, Schrama R, van Seters SP, Vanderschuren LJ, Westenberg HG. Deep brain stimulation reveals a dissociation of consummatory and motivated behaviour in the medial and lateral nucleus accumbens shell of the rat. PLoS One (2012) 7(3):e33455.10.1371/journal.pone.0033455
    1. Hill JO, Berridge K, Avena NM, Ziauddeen H, Alonso-Alonso M, Allison DB, et al. Neurocognition: the food–brain connection. Adv Nutr (2014) 5(5):544–6.10.3945/an.114.006437
    1. Kaye WH, Wierenga CE, Bailer UF, Simmons AN, Bischoff-Grethe A. Nothing tastes as good as skinny feels: the neurobiology of anorexia nervosa. Trends Neurosci (2013) 36(2):110–20.10.1016/j.tins.2013.01.003
    1. Kaye WH, Wierenga CE, Bailer UF, Simmons AN, Wagner A, Bischoff-Grethe A. Does a shared neurobiology for foods and drugs of abuse contribute to extremes of food ingestion in anorexia and bulimia nervosa? Biol Psychiatry (2013) 73(9):836–42.10.1016/j.biopsych.2013.01.002
    1. Oudijn MS, Storosum JG, Nelis E, Denys D. Is deep brain stimulation a treatment option for anorexia nervosa? BMC Psychiatry (2013) 13:277.10.1186/1471-244X-13-277
    1. Walsh BT. The enigmatic persistence of anorexia nervosa. Am J Psychiatry (2013) 170(5):477–84.10.1176/appi.ajp.2012.12081074
    1. Lochner C, Fineberg NA, Zohar J, van Ameringen M, Juven-Wetzler A, Altamura AC, et al. Comorbidity in obsessive–compulsive disorder (OCD): a report from the International College of Obsessive–Compulsive Spectrum Disorders (ICOCS). Compr Psychiatry (2014) 55(7):1513–9.10.1016/j.comppsych.2014.05.020
    1. Robbins TW, Everitt BJ. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol (1996) 6(2):228–36.10.1016/S0959-4388(96)80077-8
    1. Steinglass J, Walsh BT. Habit learning and anorexia nervosa: a cognitive neuroscience hypothesis. Int J Eat Disord (2006) 39(4):267–75.10.1002/eat.20244
    1. Godier LR, de Wit S, Pinto A, Steinglass JE, Greene AL, Scaife J, et al. An investigation of habit learning in anorexia nervosa. Psychiatry Res (2016) 244:214–22.10.1016/j.psychres.2016.07.051
    1. Gillan CM, Kosinski M, Whelan R, Phelps EA, Daw ND. Characterizing a psychiatric symptom dimension related to deficits in goal-directed control. Elife (2016) 5.10.7554/eLife.11305
    1. Gillan CM, Otto AR, Phelps EA, Daw ND. Model-based learning protects against forming habits. Cogn Affect Behav Neurosci (2015) 15(3):523–36.10.3758/s13415-015-0347-6
    1. Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry (2011) 68(7):724–31.10.1001/archgenpsychiatry.2011.74
    1. Park RJ, Singh I, Pike AC, Tan JOA. Deep brain stimulation in anorexia nervosa: hope for the hopeless or exploitation of the vulnerable? The Oxford neuroethics gold standard framework. Front Psychiatry (2017) 8:44.10.3389/fpsyt.2017.00044
    1. Denys D, Mantione M, Figee M, van den Munckhof P, Koerselman F, Westenberg H, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive–compulsive disorder. Arch Gen Psychiatry (2010) 67(10):1061–8.10.1001/archgenpsychiatry.2010.122
    1. Fairburn CG, Cooper Z, O’Connor M. Eating Disorder Examination (edition 16.0D). Cognitive Behaviour Therapy and Eating Disorders. New York: Guilford Press; (2008).
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; (2000).
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed Arlington, VA: American Psychiatric Publishing; (2013).
    1. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol (1959) 32(1):50–5.10.1111/j.2044-8341.1959.tb00467.x
    1. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 23:56–62.10.1136/jnnp.23.1.56
    1. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale–Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry (1989) 46(11):1006–11.10.1001/archpsyc.1989.01810110048007
    1. Mazure CM, Halmi KA, Sunday SR, Romano SJ, Einhorn AM. The Yale–Brown–Cornell Eating Disorder Scale: development, use, reliability and validity. J Psychiatr Res (1994) 28(5):425–45.10.1016/0022-3956(94)90002-7
    1. Fairburn CG, Beglin S. Eating Disorder Examination Questionnaire (EDE-Q 6.0). In: Fairburn C, editor. Cognitive Behaviour Therapy and Eating Disorders. New York: Guilford Press; (2008). p. 309–13.
    1. Godier LR, Park RJ. A novel measure of compulsive food restriction in anorexia nervosa: validation of the Self-Starvation Scale (SS). Eat Behav (2015) 17:10–3.10.1016/j.eatbeh.2014.12.004
    1. Bohn K, Doll HA, Cooper Z, O’Connor M, Palmer RL, Fairburn CG. The measurement of impairment due to eating disorder psychopathology. Behav Res Ther (2008) 46(10):1105–10.10.1016/j.brat.2008.06.012
    1. Skevington SM. Measuring quality of life in Britain: introducing the WHOQOL-100. J Psychosom Res (1999) 47(5):449–59.10.1016/S0022-3999(99)00051-3
    1. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; (1996).
    1. Spielberger CD. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Mind Garden; (1983).
    1. Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith–Hamilton Pleasure Scale. Br J Psychiatry (1995) 167(1):99–103.10.1192/bjp.167.1.99
    1. Cowdrey FA, Park RJ. Assessing rumination in eating disorders: principal component analysis of a minimally modified ruminative response scale. Eat Behav (2011) 12(4):321–4.10.1016/j.eatbeh.2011.08.001
    1. Wechsler D. Wechsler Adult Intelligence Scale. 4th ed San Antonio, TX: Pearson; (2008).
    1. Coughlan AK, Oddy M, Crawford AR. BIRT Memory and Information Processing Battery (BMIPB). London: Brain Injury Rehabilitation Trust; (2007).
    1. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms and Commentary. New York: Oxford University Press; (1998).
    1. Meyers JE, Meyers KR. Rey Complex Figure (RCF) Task. Lutz, USA: PAR; (1995).
    1. Bechara A. Iowa Gambling Task: Professional Manual. Lutz, Florida, USA: PAR; (2007).
    1. Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests. 3rd ed New York, USA: Oxford University Press; (2006).
    1. Delis DC, Kaplan E, Kramer JH. Delis Kaplan Executive Function System. San Antonio, USA: The Psychological Corporation; (2001).
    1. Zigmund AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 67:361–70.10.1111/j.1600-0447.1983.tb09716.x
    1. Appelbaum PS, Grisso T. MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR). Sarasota, FL: Professional Resource Press; (2001).
    1. Nuttin B, Wu H, Mayberg H, Hariz M, Gabriels L, Galert T, et al. Consensus on guidelines for stereotactic neurosurgery for psychiatric disorders. J Neurol Neurosurg Psychiatry (2014) 85(9):1003–8.10.1136/jnnp-2013-306580
    1. Nuffield Council on Bioethics. Novel Neurotechnologies: Intervening in the Brain. London: Nuffield Council on Bioethics; (2013).
    1. CANTAB® [Cognitive Assessment Software]. Cambridge Cognition (2017). Available from:
    1. Clyde DJ. SAFTEE: data system for side effect assessment scale. Psychopharmacol Bull (1986) 22(1):287.
    1. Brunoni AR, Amadera J, Berbel B, Volz MS, Rizzerio BG, Fregni F. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int J Neuropsychopharmacol (2011) 14(8):1133–45.10.1017/S1461145710001690

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever